MediPal Holdings Corporation (FRA:59Z)

Market Cap	3.12B +3.1%
Revenue (ttm)	21.56B +3.9%
Net Income	234.07M -11.7%
EPS	1.13 -10.7%
Shares Out	n/a
PE Ratio	13.35
Forward PE	n/a
Dividend	0.38 (2.56%)
Ex-Dividend Date	Sep 29, 2025

Volume	n/a
Average Volume	30
Open	15.00
Previous Close	15.00
Day's Range	14.80 - 15.00
52-Week Range	13.30 - 15.90
Beta	n/a
RSI	50.13
Earnings Date	Feb 9, 2026

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health product...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1898
• Employees: 13,061
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 59Z

Financial Performance

In fiscal year 2025, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.

Financial numbers in JPY